Cause‐specific mortality following polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the US population, 2001–2017-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cause‐specific mortality following polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the US population, 2001–2017

Published:2021-10-11 Issue:12 Volume:96 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Dores Graça M.¹²^ORCID,Curtis Rochelle E.¹,Linet Martha S.¹^ORCID,Morton Lindsay M.¹^ORCID

Affiliation:

1. Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute National Institutes of Health Bethesda Maryland USA

2. Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology, Office of Pharmacovigilance and Epidemiology, Division of Pharmacovigilance‐II U.S. Food and Drug Administration Silver Spring Maryland USA

Funder

Division of Cancer Epidemiology and Genetics, National Cancer Institute

National Institutes of Health

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26362

Reference6 articles.

1. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease

2. Clinical insights into the origins of thrombosis in myeloproliferative neoplasms

3. Clonal hematopoiesis and nonhematologic disorders;Jaiswal S;Blood,2020

4. Two-fold risk of pneumonia and respiratory mortality in individuals with myeloproliferative neoplasm: A population-based cohort study

5. Pulmonary toxicity of antineoplastic therapy;Kreisman H;Semin Oncol,1992

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloproliferative Neoplasms: Contemporary Review and Molecular Landscape;International Journal of Molecular Sciences;2023-12-12

2. Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study;Cancers;2023-09-24

3. Risks of therapy-related hematologic neoplasms beyond myelodysplastic syndromes and acute myeloid leukemia;Blood;2023-02-23

4. Primary myelofibrosis: 2023 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2023-02-06

5. Myelofibrosis;Blood;2022-11-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3